C‐reactive protein and leucocyte activation in psoriasis <i>vulgaris</i> according to severity and therapy

Abstract

We propose CRP as a useful marker of psoriasis severity that could be used to monitor psoriasis and its treatment, and, together with PASI and elastase, could also be used as a global index of severity.